Skip to main content
Journal ArticleOPEN ACCESS

Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis

  • Singh A
  • Carroll K
  • Perkovic V
  • et al.
New England Journal of Medicine (2021) 385(25) 2325-2335
DOI: 10.1056/nejmoa2113379
122Citations
Citations of this article
190Readers
Mendeley users who have this article in their library.

Abstract

Abstract Background Among patients with chronic kidney disease (CKD), the use of recombinant human erythropoietin and its derivatives for the treatment of anemia has been linked to a possibly incre...

Cite

CITATION STYLE

APA

Singh, A. K., Carroll, K., Perkovic, V., Solomon, S., Jha, V., Johansen, K. L., … McMurray, J. J. V. (2021). Daprodustat for the Treatment of Anemia in Patients Undergoing Dialysis. New England Journal of Medicine, 385(25), 2325–2335. https://doi.org/10.1056/nejmoa2113379

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free